What does PHARMA-SANA do?

PHARMA-SANA is a pharmacy in Schaarbeek. Private Limited, started on 26 September 2006, 1 establishment.

What is the address of PHARMA-SANA?

The registered office of PHARMA-SANA is located at François Bossaertsstraat 39, 1030 Schaarbeek.

Is PHARMA-SANA still active?

Yes. According to the CBE (4 October 2026) PHARMA-SANA is active, legal situation “Normale toestand”, started on 26 September 2006.

Is PHARMA-SANA registered on Peppol?

Yes, PHARMA-SANA is registered on the Peppol network with ID 0208:0883740769.

What is the enterprise number of PHARMA-SANA?

The enterprise number of PHARMA-SANA is BE0883740769.

When was PHARMA-SANA founded?

PHARMA-SANA was founded on 26 September 2006.

Who are the directors of PHARMA-SANA?

According to the 2025 annual accounts, the directors of PHARMA-SANA are: Mounir BEKRI.

Is PHARMA-SANA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 September 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMA-SANA make in 2025?

PHARMA-SANA posted a profit after taxes of € 135,482 in financial year 2025.

What is the revenue of PHARMA-SANA?

As a small company, PHARMA-SANA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 243,749.

PHARMA-SANA (Private Limited) - Schaarbeek - BE0883740769

Dossier PHARMA-SANA, printed on 4 October 2026 from databakkes.be/en/0883740769/pharma-sana. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMA-SANA from Schaarbeek, company number BE0883740769, closed financial year 2025 with a result of € 135,482 after tax. For that financial year PHARMA-SANA recorded a gross margin of € 243,749 and equity of € 306,818. Compared with financial year 2024, the result moved from € 37,605 to € 135,482. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 25, 2026.

What it is worth Growing

€ 306,818

▲ 79% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 135,482

▲ 260% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 169,888

▲ € 166,551 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 286,818.

People and assets in 2025

Vehicles and equipment

€ 4,785

▲ 200% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 79,333

▼ 32% vs 2024

€ 37,743 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 36,651

▼ 58% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 65,102

▲ € 53,607 vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 73,400 Gross margin 2022: € 73,400 First fiscal year in the series	€ 55,368 Gross margin 2023: € 55,368 ▼ 25% vs 2022 (€ 73,400) Unfavourable step	€ 90,675 Gross margin 2024: € 90,675 ▲ 64% vs 2023 (€ 55,368) Favourable step	€ 243,749 Gross margin 2025: € 243,749 ▲ 169% vs 2024 (€ 90,675) Favourable step	▲ 169%
Profit after taxes	€ 20,938 Profit after taxes 2022: € 20,938 First fiscal year in the series	€ 9,069 Profit after taxes 2023: € 9,069 ▼ 57% vs 2022 (€ 20,938) Unfavourable step	€ 37,605 Profit after taxes 2024: € 37,605 ▲ € 28,536 vs 2023 (€ 9,069) Favourable step	€ 135,482 Profit after taxes 2025: € 135,482 ▲ 260% vs 2024 (€ 37,605) Favourable step	▲ 260%
Equity	€ 124,662 Equity 2022: € 124,662 First fiscal year in the series	€ 133,730 Equity 2023: € 133,730 ▲ 7% vs 2022 (€ 124,662) Favourable step	€ 171,336 Equity 2024: € 171,336 ▲ 28% vs 2023 (€ 133,730) Favourable step	€ 306,818 Equity 2025: € 306,818 ▲ 79% vs 2024 (€ 171,336) Favourable step	▲ 79%
Total debts	€ 376,377 Total debts 2022: € 376,377 First fiscal year in the series	€ 324,922 Total debts 2023: € 324,922 ▼ 14% vs 2022 (€ 376,377) Favourable step	€ 214,571 Total debts 2024: € 214,571 ▼ 34% vs 2023 (€ 324,922) Favourable step	€ 181,086 Total debts 2025: € 181,086 ▼ 16% vs 2024 (€ 214,571) Favourable step	▼ 16%
Cash	€ 94,404 Cash 2022: € 94,404 First fiscal year in the series	€ 58,212 Cash 2023: € 58,212 ▼ 38% vs 2022 (€ 94,404) Unfavourable step	€ 3,338 Cash 2024: € 3,338 ▼ 94% vs 2023 (€ 58,212) Unfavourable step	€ 169,888 Cash 2025: € 169,888 ▲ € 166,551 vs 2024 (€ 3,338) Favourable step	▲ € 166,551
Land & buildings	€ 300,034 Land & buildings 2022: € 300,034 First fiscal year in the series	€ 286,416 Land & buildings 2023: € 286,416 ▼ 5% vs 2022 (€ 300,034) Unchanged	€ 272,661 Land & buildings 2024: € 272,661 ▼ 5% vs 2023 (€ 286,416) Unchanged	€ 258,906 Land & buildings 2025: € 258,906 ▼ 5% vs 2024 (€ 272,661) Unchanged	▼ 5%
Retained profit	€ 104,662 Retained profit 2022: € 104,662 First fiscal year in the series	€ 113,730 Retained profit 2023: € 113,730 ▲ 9% vs 2022 (€ 104,662) Favourable step	€ 151,336 Retained profit 2024: € 151,336 ▲ 33% vs 2023 (€ 113,730) Favourable step	€ 286,818 Retained profit 2025: € 286,818 ▲ 90% vs 2024 (€ 151,336) Favourable step	▲ 90%
Bank debt	€ 221,273 Bank debt 2022: € 221,273 First fiscal year in the series	€ 159,933 Bank debt 2023: € 159,933 ▼ 28% vs 2022 (€ 221,273) Favourable step	€ 116,253 Bank debt 2024: € 116,253 ▼ 27% vs 2023 (€ 159,933) Favourable step	€ 79,333 Bank debt 2025: € 79,333 ▼ 32% vs 2024 (€ 116,253) Favourable step	▼ 32%
Balance sheet total	€ 501,039 Balance sheet total 2022: € 501,039 First fiscal year in the series	€ 458,653 Balance sheet total 2023: € 458,653 ▼ 8% vs 2022 (€ 501,039) Unchanged	€ 385,907 Balance sheet total 2024: € 385,907 ▼ 16% vs 2023 (€ 458,653) Unchanged	€ 487,904 Balance sheet total 2025: € 487,904 ▲ 26% vs 2024 (€ 385,907) Unchanged	▲ 26%

Key figures of PHARMA-SANA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMA-SANA?

What happened at PHARMA-SANA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 25, 2026 New annual accounts for financial year 2025: profit of € 135,482 (▲ 260% vs 2024). filed late Source: NBB ↗
Oct 27, 2006 New establishment in Schaarbeek. KBO
Sep 26, 2006 Start of the company according to the CBE. KBO

In short

From € 20,938 profit in 2022 to € 135,482 profit in 2025.

Paid € 95,466 in corporate taxes since 2022.

Best year ever: 2025, with € 135,482 profit.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMA-SANA? We notify you, reason included.

Follow PHARMA-SANA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Mounir BEKRI

PHARMA-SANA

Behind PHARMA-SANA is Mounir BEKRI.

See the full network in the app

Directors

According to the 2025 annual accounts

Mounir BEKRI

Director

Establishments

Establishment units

Physical locations of this company

Registered office

François Bossaertsstraat 39

1030 Schaarbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0883.740.769

VAT number

BE 0883.740.769

Registered office

François Bossaertsstraat 39, 1030 Schaarbeek

Names & denominations

PHARMA-SANA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 September 2006

Peppol

Active · Active since 21 Jan 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMA-SANA

Financials

What happened to PHARMA-SANA?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions